$TLYS
TILLY'S, INC.

2020 Q3 Form 10-Q Financial Statement

#000162827920000210 Filed on September 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q1 2019 Q3
Revenue $135.8M $172.5M $161.7M
YoY Change -16.01% 1.09% 2.75%
Cost Of Revenue $94.17M $120.3M $110.0M
YoY Change -14.4% 1.52% 2.53%
Gross Profit $41.67M $52.13M $51.72M
YoY Change -19.42% -0.04% 3.22%
Gross Profit Margin 30.68% 30.23% 31.98%
Selling, General & Admin $33.97M $43.30M $39.61M
YoY Change -14.25% 5.1% 5.27%
% of Gross Profit 81.5% 83.06% 76.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.970M $5.620M $5.080M
YoY Change -2.17% 1.81% -10.56%
% of Gross Profit 11.93% 10.78% 9.82%
Operating Expenses $33.97M $43.40M $39.61M
YoY Change -14.25% 5.34% 5.27%
Operating Profit $7.709M $8.495M $12.11M
YoY Change -36.34% -22.31% -2.95%
Interest Expense $300.0K
YoY Change
% of Operating Profit 3.89%
Other Income/Expense, Net $311.0K $600.0K $572.0K
YoY Change -45.63% -33.33% 16.73%
Pretax Income $8.020M $9.100M $12.68M
YoY Change -36.76% -22.88% -2.21%
Income Tax $2.754M $2.800M $3.398M
% Of Pretax Income 34.34% 30.77% 26.79%
Net Earnings $5.266M $6.273M $9.284M
YoY Change -43.28% -27.71% -4.18%
Net Earnings / Revenue 3.88% 3.64% 5.74%
Basic Earnings Per Share $0.18 $0.21 $0.31
Diluted Earnings Per Share $0.18 $0.21 $0.31
COMMON SHARES
Basic Shares Outstanding 29.69M shares 29.51M shares
Diluted Shares Outstanding 29.70M shares 29.68M shares

Balance Sheet

Concept 2020 Q3 2020 Q1 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $148.9M $139.6M $124.5M
YoY Change 19.62% -2.89% 0.3%
Cash & Equivalents $133.0M $70.14M $62.39M
Short-Term Investments $15.94M $69.49M $62.09M
Other Short-Term Assets $4.000M $630.0K $4.800M
YoY Change -16.67% -31.22% -47.25%
Inventory $68.07M $56.90M $72.64M
Prepaid Expenses
Receivables $13.30M $7.500M $11.80M
Other Receivables $0.00 $274.0K $0.00
Total Short-Term Assets $234.2M $208.9M $214.0M
YoY Change 9.42% -3.81% -2.39%
LONG-TERM ASSETS
Property, Plant & Equipment $56.81M $66.18M $68.01M
YoY Change -16.48% -10.38% -13.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.458M $7.951M $2.194M
YoY Change 285.51% 263.89% -35.3%
Total Long-Term Assets $310.3M $337.8M $326.3M
YoY Change -4.9% 344.28% 296.43%
TOTAL ASSETS
Total Short-Term Assets $234.2M $208.9M $214.0M
Total Long-Term Assets $310.3M $337.8M $326.3M
Total Assets $544.5M $546.6M $540.3M
YoY Change 0.77% 86.46% 79.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.71M $20.56M $39.48M
YoY Change 23.39% -15.06% -7.74%
Accrued Expenses $19.42M $20.76M $23.11M
YoY Change -15.99% 10.66% -21.71%
Deferred Revenue $1.800M $2.400M $1.800M
YoY Change 0.0%
Short-Term Debt $23.70M $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $172.9M $145.3M $130.8M
YoY Change 32.23% 49.36% 41.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $944.0K $718.0K $1.182M
YoY Change -20.14% -59.13% -47.14%
Total Long-Term Liabilities $944.0K $241.5M $1.182M
YoY Change -20.14% 641.12% -47.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $172.9M $145.3M $130.8M
Total Long-Term Liabilities $944.0K $241.5M $1.182M
Total Liabilities $395.9M $386.7M $365.9M
YoY Change 8.21% 197.86% 189.82%
SHAREHOLDERS EQUITY
Retained Earnings -$5.849M $6.280M $23.30M
YoY Change -125.11% -52.91% -18.99%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $148.6M $159.9M $174.4M
YoY Change
Total Liabilities & Shareholders Equity $544.5M $546.6M $540.3M
YoY Change 0.77% 86.46% 79.15%

Cashflow Statement

Concept 2020 Q3 2020 Q1 2019 Q3
OPERATING ACTIVITIES
Net Income $5.266M $6.273M $9.284M
YoY Change -43.28% -27.71% -4.18%
Depreciation, Depletion And Amortization $4.970M $5.620M $5.080M
YoY Change -2.17% 1.81% -10.56%
Cash From Operating Activities $38.41M $11.93M $16.37M
YoY Change 134.64% -56.55% -23.07%
INVESTING ACTIVITIES
Capital Expenditures -$700.0K -$3.660M -$1.790M
YoY Change -60.89% -19.21% -51.88%
Acquisitions
YoY Change
Other Investing Activities $30.12M -$6.900M $13.95M
YoY Change 115.91% -133.79% -196.27%
Cash From Investing Activities $29.42M -$10.57M $12.16M
YoY Change 141.94% -166.48% -166.78%
FINANCING ACTIVITIES
Cash Dividend Paid $29.70M
YoY Change 0.68%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 1.180M 0.000
YoY Change 2850.0% -100.0%
NET CHANGE
Cash From Operating Activities 38.41M 11.93M 16.37M
Cash From Investing Activities 29.42M -10.57M 12.16M
Cash From Financing Activities 0.000 1.180M 0.000
Net Change In Cash 67.83M 2.540M 28.53M
YoY Change 137.75% -94.15% 541.12%
FREE CASH FLOW
Cash From Operating Activities $38.41M $11.93M $16.37M
Capital Expenditures -$700.0K -$3.660M -$1.790M
Free Cash Flow $39.11M $15.59M $18.16M
YoY Change 115.36% -51.27% -27.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
263649000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
256048000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56805000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66176000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
68010000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8458000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7951000 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2194000 USD
CY2020Q3 us-gaap Assets
Assets
543507000 USD
CY2020Q1 us-gaap Assets
Assets
546640000 USD
CY2019Q3 us-gaap Assets
Assets
540291000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
48710000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
20562000 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
39475000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19416000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20755000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23112000 USD
CY2020Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
23675000 USD
CY2020Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2019Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9443000 USD
CY2020Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
11761000 USD
CY2019Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8330000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6891000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7190000 USD
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6132000 USD
CY2020Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2020Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
29677000 USD
CY2019Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64470000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
55321000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
53744000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
172605000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
145266000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
130793000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
222015000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
240755000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
233876000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
319000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
718000 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1182000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
394939000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
386739000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
365851000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
dei Amendment Flag
AmendmentFlag
false
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
154386000 USD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-01
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Central Index Key
EntityCentralIndexKey
0001524025
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
153377000 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
150877000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5849000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6280000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
23296000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000 USD
us-gaap Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
We are required to maintain certain financial and non-financial covenants in accordance with the line of credit. The financial covenants require certain levels of leverage and profitability, such as (i) income before income taxes not to be less than $1.0 million (calculated at the end of each fiscal quarter on a trailing 12-month basis), (ii) a maximum ratio of 4.00 to 1.00 as of each quarter end for “Funded Debt to EBITDAR”, defined as the sum of total debt, capital leases and annual rent expense multiplied by six divided by the sum of net income, interest expense, taxes, depreciation, amortization and annual rent expense on a trailing 12-month basis, and (iii) requires minimum eligible inventory, cash, cash equivalents and marketable securities totaling $50.0 million as of the end of each quarter. In addition, maximum investment in fixed assets in any fiscal year of $50.0 million.
us-gaap Debt Instrument Interest Rate Terms
DebtInstrumentInterestRateTerms
The interest rate charged on borrowings is selected at our discretion at the time of draw between the London Interbank Offered Rate, plus 0.75%, or at the Bank’s prime rate.
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
214000 USD
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-08-01
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35535
dei Entity Registrant Name
EntityRegistrantName
TILLY’S, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2164791
dei Entity Address Address Line1
EntityAddressAddressLine1
10 Whatney
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
609-5599
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
TLYS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132955000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70137000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62388000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
15939000 USD
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
237000 USD
CY2020Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
69780000 USD
CY2019Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
62413000 USD
CY2020Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
13287000 USD
CY2020Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
7485000 USD
CY2019Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
11758000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
68067000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
56901000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
72635000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3956000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4561000 USD
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4845000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
234204000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
208864000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
214039000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
244040000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
311000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
572000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
148568000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
720000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1401000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
159901000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
174440000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8020000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
543507000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12682000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
546640000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
540291000 USD
CY2020Q3 us-gaap Revenues
Revenues
135845000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-19972000 USD
CY2019Q3 us-gaap Revenues
Revenues
161738000 USD
us-gaap Revenues
Revenues
213134000 USD
us-gaap Revenues
Revenues
292041000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94171000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
110019000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
169866000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
204638000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
41674000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
51719000 USD
us-gaap Gross Profit
GrossProfit
43268000 USD
us-gaap Gross Profit
GrossProfit
87403000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13657000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2754000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3398000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33965000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39609000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63960000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75147000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7709000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
12110000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-20692000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
12256000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29686000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29487000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29700000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29678000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7843000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29686000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3696000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
5266000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
9284000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12129000 USD
us-gaap Net Income Loss
NetIncomeLoss
9961000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29694000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29505000 shares
us-gaap Net Income Loss
NetIncomeLoss
9961000 USD
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
70000 shares
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
8000 shares
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1009000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29739000 shares
us-gaap Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation
85000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
5266000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
9284000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12129000 USD
us-gaap Net Income Loss
NetIncomeLoss
9961000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-200000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
80000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-213000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
11000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-200000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1075000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
18000 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
151000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
80000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-213000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5066000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9364000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12342000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9972000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
159901000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12129000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
11000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-213000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
148568000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
11000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
163327000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
848000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-490000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
174440000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12129000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-218000 USD
us-gaap Net Income Loss
NetIncomeLoss
9961000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
5802000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9987000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10286000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-64000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1009000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1075000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-145000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
677000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
903000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2318000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15055000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2043000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-299000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3605000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11166000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16826000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2107000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-717000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28376000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
701000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4243000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
62079000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4848000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15968000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2798000 USD
tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
8577000 USD
tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-1059000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18843000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14085000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4250000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
70195000 USD
CY2020Q3 tlys Lessee Operating Lease Lease Notyet Commenced Assumptionand Judgment Value
LesseeOperatingLeaseLeaseNotyetCommencedAssumptionandJudgmentValue
14000000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0426
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
76457000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
49977000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9530000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
23675000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
29677000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
29453000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
151000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
85000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6002000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29387000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
62818000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5772000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70137000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68160000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132955000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62388000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
15288000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1845000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2012000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7168 USD
us-gaap Interest Paid Net
InterestPaidNet
128000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
828000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4647000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
313602 USD
CY2020Q3 us-gaap Number Of Stores
NumberOfStores
238 store
CY2020Q3 tlys Numberof Pop Up Stores
NumberofPopUpStores
1 store
CY2020Q3 tlys Number Of States
NumberOfStates
33 State
us-gaap Fiscal Period
FiscalPeriod
<div style="line-height:120%;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our fiscal year ends on the Saturday closest to January 31. References to fiscal 2020 refer to the fiscal year ending January 30, 2021. References to the fiscal quarters or first halves ended </span><span style="font-family:inherit;font-size:10pt;">August 1, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">August 3, 2019</span><span style="font-family:inherit;font-size:10pt;"> refer to the </span><span style="font-family:inherit;font-size:10pt;">thirteen and twenty-six week periods ended</span><span style="font-family:inherit;font-size:10pt;"> as of those dates, respectively.</span></div>
CY2020Q3 us-gaap Revenues
Revenues
135845000 USD
CY2019Q3 us-gaap Revenues
Revenues
161738000 USD
us-gaap Revenues
Revenues
213134000 USD
us-gaap Revenues
Revenues
292041000 USD
CY2020Q3 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2019Q3 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2020Q3 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2019Q3 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2020Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
2100000 USD
CY2020Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1400000 USD
CY2019Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3300000 USD
CY2020Q3 us-gaap Accrued Liabilities For Unredeeemed Gift Cards
AccruedLiabilitiesForUnredeeemedGiftCards
7700000 USD
CY2020Q1 us-gaap Accrued Liabilities For Unredeeemed Gift Cards
AccruedLiabilitiesForUnredeeemedGiftCards
9300000 USD
CY2019Q3 us-gaap Accrued Liabilities For Unredeeemed Gift Cards
AccruedLiabilitiesForUnredeeemedGiftCards
6600000 USD
us-gaap Lease Cost
LeaseCost
39497000 USD
us-gaap Lease Cost
LeaseCost
39693000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
77534000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
323360000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
36875000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
286485000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
20446000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
tlys Unredeemed Awardsand Accumulated Points Expiration Period
UnredeemedAwardsandAccumulatedPointsExpirationPeriod
P365D
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1800000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2400000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1800000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
31203000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
31707000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
8294000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
7986000 USD
CY2020Q3 tlys Operating Lease Withheld Lease Payments
OperatingLeaseWithheldLeasePayments
13900000 USD
CY2020Q3 tlys Percentageof Stores
PercentageofStores
0.70
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
43239000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
62782000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
56447000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
47159000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
36199000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
15863000 USD
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
4453000 USD
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
4078000 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
19741000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
19941000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7800000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.393
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3700000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.271
CY2020Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
2300000 USD
CY2019Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
62413000 USD
CY2020Q3 us-gaap Marketable Securities
MarketableSecurities
15938000 USD
CY2020Q3 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
1000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
15939000 USD
CY2020Q1 us-gaap Marketable Securities
MarketableSecurities
69487000 USD
CY2020Q1 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
293000 USD
CY2020Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
69780000 USD
CY2019Q3 us-gaap Marketable Securities
MarketableSecurities
62088000 USD
CY2019Q3 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
325000 USD
CY2014Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
25000000.0 USD
CY2020Q1 us-gaap Line Of Credit
LineOfCredit
23700000 USD
CY2020Q2 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.009
tlys Debt Covenant Multiple
DebtCovenantMultiple
6
CY2020Q3 tlys Debt Instrument Covenant Minimum Eligible Inventory
DebtInstrumentCovenantMinimumEligibleInventory
50000000.0 USD
CY2020Q3 tlys Debt Instrument Covenant Minimum Eligible Inventory
DebtInstrumentCovenantMinimumEligibleInventory
50000000.0 USD
CY2020Q3 tlys Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
0.8
CY2020Q3 tlys Leverage Ratio On Credit Facility
LeverageRatioOnCreditFacility
4.9
tlys Income Before Income Taxes Trailing12 Month Basis
IncomeBeforeIncomeTaxesTrailing12MonthBasis
-2300000 USD
tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
10 store
us-gaap Asset Impairment Charges
AssetImpairmentCharges
900000 USD
CY2020Q3 tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
570000 USD
tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
903000 USD
CY2020Q3 tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
0 USD
tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
0 USD
CY2020Q3 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
37 store
CY2019Q3 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
3 store
tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
40 store
tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
4 store
CY2020Q3 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
7 store
CY2019Q3 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
0 store
tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
10 store
tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
0 store
tlys Percentage Of Awards Vesting On Grant Date
PercentageOfAwardsVestingOnGrantDate
0.25
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1993187 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.50
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
641900 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
38937 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2813 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
11.33
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2593337 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.22
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1131000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1249943 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.04
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M18D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.50
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.573
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.532
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.024
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Net Income Loss
NetIncomeLoss
-12129000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
508000 USD
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
546000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1009000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1075000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4700000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
5266000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
9284000 USD
us-gaap Net Income Loss
NetIncomeLoss
9961000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29694000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29505000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29686000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29487000 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6000 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
173000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
252000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29700000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29678000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29686000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29739000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2644000 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1392000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2665000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1367000 shares

Files In Submission

Name View Source Status
0001628279-20-000210-index-headers.html Edgar Link pending
0001628279-20-000210-index.html Edgar Link pending
0001628279-20-000210.txt Edgar Link pending
0001628279-20-000210-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q2202010-q.htm Edgar Link pending
q2202010-q_htm.xml Edgar Link completed
q22020ex311.htm Edgar Link pending
q22020ex312.htm Edgar Link pending
q22020ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlys-20200801.xsd Edgar Link pending
tlys-20200801_cal.xml Edgar Link unprocessable
tlys-20200801_def.xml Edgar Link unprocessable
tlys-20200801_lab.xml Edgar Link unprocessable
tlys-20200801_pre.xml Edgar Link unprocessable